Zopiclone: Is there any dependence and abuse potential?

被引:0
|
作者
Malcolm Lader
机构
[1] University of London,Department of Psychiatry, Section of Clinical Psychopharmacology
[2] Institute of Psychiatry,undefined
来源
Journal of Neurology | 1997年 / 244卷
关键词
Zopiclone; Dependence potential; Abuse potential; Hypnotics;
D O I
暂无
中图分类号
学科分类号
摘要
Both published and unpublished data concerning the rebound, withdrawal, dependence and abuse potential of zopiclone have been reviewed. As expected for an hypnotic drug of about 5 h elimination half-life, rebound has occasionally been detected but is substantially less frequent than with equivalent benzodiazepines. Tolerance to zopiclone does not occur regularly and cross-tolerance to the benzodiazepines may help in a regimen to withdraw from the latter drugs. Dependence on long-term use, as shown by either a characteristic withdrawal syndrome or by psychological craving, is rare considering the world-wide extent of usage. Abuse (addictive non-medical use) is documented but is also rare, in comparison with the widely abused benzodiazepines. It is concluded that zopiclone has substantial advantages over the benzodiazepines in terms of dependence and abuse potential.
引用
收藏
页码:S18 / S22
相关论文
共 50 条
  • [41] Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
    Bossard, Jean-Baptiste
    Ponte, Camille
    Dupouy, Julie
    Lapeyre-Mestre, Maryse
    Jouanjus, Emilie
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (09) : 735 - 742
  • [42] A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler
    West, R
    Hajek, P
    Foulds, J
    Nilsson, F
    May, S
    Meadows, A
    [J]. PSYCHOPHARMACOLOGY, 2000, 149 (03) : 198 - 202
  • [43] Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
    Jean-Baptiste Bossard
    Camille Ponté
    Julie Dupouy
    Maryse Lapeyre-Mestre
    Emilie Jouanjus
    [J]. Clinical Drug Investigation, 2016, 36 : 735 - 742
  • [44] PHYSICAL-DEPENDENCE FOLLOWING ZOPICLONE USAGE - A CASE-REPORT
    THAKORE, J
    DINAN, TG
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (02) : 143 - 145
  • [45] Gamma-hydroxybutyric acid - Efficacy, potential abuse, and dependence in the treatment of alcohol addiction
    Addolorato, G
    Caputo, F
    Capristo, E
    Stefanini, GF
    Gasbarrini, G
    [J]. ALCOHOL, 2000, 20 (03) : 217 - 222
  • [46] WHAT IF AMERICANS DRANK LESS - THE POTENTIAL EFFECT ON THE PREVALENCE OF ALCOHOL-ABUSE AND DEPENDENCE
    ARCHER, L
    GRANT, BF
    DAWSON, DA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (01) : 61 - 66
  • [47] Impact of sex in three paradigms evaluating the abuse and dependence potential of new chemical entities
    Colleaux, C. Froger
    Sable, E.
    Babin, D.
    Rochais, Q.
    Castagne, V.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S307 - S307
  • [49] The clinical efficacy and abuse potential of combination buprenorphive-naloxone in the treatment of opioid dependence
    Mammen, Kristie
    Bell, James
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2537 - 2544
  • [50] POTENTIAL FOR ABUSE
    WILLIAMS, ARF
    [J]. CANADIAN FAMILY PHYSICIAN, 1995, 41 : 559 - 559